Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-25 Dubois-Stringfellow Nathalie SVP-Chief Development Officer Shares withheld for taxes −1,462 $1.33 $2K 137,096
2023-05-25 Fontenot Jason D. SVP, Chief Scientific Officer Shares withheld for taxes −1,029 $1.33 $1K 138,329
2023-05-25 Duraibabu Prathyusha SVP, Chief Financial Officer Shares withheld for taxes −1,328 $1.33 $2K 132,052
2023-05-25 Macrae Sandy President, CEO and Director Shares withheld for taxes −10,411 $1.33 $14K 613,298
2023-04-24 Willoughby Scott B. SVP, Gen. Counsel & Secretary Shares withheld for taxes −3,977 $1.65 $7K 126,612
2023-03-25 Duraibabu Prathyusha SVP, Chief Financial Officer Shares withheld for taxes −345 $1.66 $573 133,380
2023-02-25 Willoughby Scott B. SVP, Gen. Counsel & Secretary Shares withheld for taxes −5,128 $2.66 $14K 130,589
2023-02-25 Ramelmeier Rolf Andrew EVP, Technical Operations Shares withheld for taxes −15,618 $2.66 $42K 173,217
2023-02-25 McClung David Mark EVP, Chief Operating Officer Shares withheld for taxes −9,745 $2.66 $26K 224,774
2023-02-25 Dubois-Stringfellow Nathalie SVP-Chief Development Officer Shares withheld for taxes −9,834 $2.66 $26K 138,558
2023-02-25 Fontenot Jason D. SVP, Chief Scientific Officer Shares withheld for taxes −6,559 $2.66 $17K 139,358
2023-02-25 Duraibabu Prathyusha SVP, Chief Financial Officer Shares withheld for taxes −7,030 $2.66 $19K 133,725
2023-02-25 Macrae Sandy President, CEO and Director Shares withheld for taxes −54,767 $2.66 $146K 623,709
2023-02-24 Willoughby Scott B. SVP, Gen. Counsel & Secretary Grant or award +42,750 135,717
2023-02-24 Willoughby Scott B. SVP, Gen. Counsel & Secretary Grant or award · Stock Option (Right to Buy) +199,500 199,500
2023-02-24 Ramelmeier Rolf Andrew EVP, Technical Operations Grant or award +45,000 188,835
2023-02-24 Ramelmeier Rolf Andrew EVP, Technical Operations Grant or award · Stock Option (Right to Buy) +210,000 210,000
2023-02-24 McClung David Mark EVP, Chief Operating Officer Grant or award +56,250 234,519
2023-02-24 McClung David Mark EVP, Chief Operating Officer Grant or award · Stock Option (Right to Buy) +262,500 262,500
2023-02-24 Dubois-Stringfellow Nathalie SVP-Chief Development Officer Grant or award +53,438 148,392

Page 11 of 17 · 338 trades